Selected article for: "adjusted multivariable model and logistic regression"

Author: Barlass, Usman; Wiliams, Brett; Dhana, Klodian; Adnan, Darbaz; Khan, Shahab R.; Mahdavinia, Mahboobeh; Bishehsari, Faraz
Title: Marked Elevation of Lipase in COVID-19 Disease: A Cohort Study
  • Cord-id: g2dnesoq
  • Document date: 2020_7_16
  • ID: g2dnesoq
    Snippet: INTRODUCTION: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causing the pandemic of coronavirus disease 2019 (COVID-19) is a global health crisis. Possible pancreatic involvement has recently been observed in these patients; however, its significance is unclear. The aim of this study was to evaluate the association of significantly elevated lipase with disease outcomes. METHODS: Data about demographics, symptoms, laboratory values, and clinical outcomes were collected for 1,003 co
    Document: INTRODUCTION: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causing the pandemic of coronavirus disease 2019 (COVID-19) is a global health crisis. Possible pancreatic involvement has recently been observed in these patients; however, its significance is unclear. The aim of this study was to evaluate the association of significantly elevated lipase with disease outcomes. METHODS: Data about demographics, symptoms, laboratory values, and clinical outcomes were collected for 1,003 consecutive patients testing positive for COVID-19. Elevated lipase was defined as greater than 3 times the upper limit of normal (>3 × ULN). Baseline characteristics among patients with or without elevated lipase were compared using Fisher exact test or Student t-test for categorical or numerical variables, respectively. Logistic regression was used to evaluate the association of lipase levels with primary clinical outcomes (intensive care unit admission and intubation) adjusted for age, sex, body mass index, history of diabetes, and hypertension. RESULTS: Of 1,003 patients with COVID-19, 83 had available lipase levels and were all admitted to the hospital. Of 83, 14 (16.8%) had elevated lipase (>3 × ULN), which was associated with higher rates of leukocytosis (P < 0.001) and abnormal liver enzymes (P < 0.01). Compared with lower lipase levels (<3 × ULN), patients with elevated lipase had higher rates of ICU admission (92.9% vs 32.8%; P < 0.001) and intubation (78.6% vs 23.5%; P 0.002). In a multivariable-adjusted model, higher lipase levels were significantly associated with admission to the ICU and rate of intubation. DISCUSSION: Lipase elevation is seen in COVID-19 and is associated with worse disease outcomes.

    Search related documents:
    Co phrase search for related documents
    • abdominal imaging and admission course: 1
    • abdominal imaging and logistic regression: 1, 2, 3, 4
    • abdominal pain and acute pancreatitis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • abdominal pain and acute pancreatitis present: 1, 2, 3, 4
    • abdominal pain and admission 11: 1, 2, 3
    • abdominal pain and admission intubation: 1
    • abdominal pain and liver enzyme: 1, 2, 3, 4, 5, 6, 7, 8
    • abdominal pain and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • abdominal pain vomiting and acute pancreatitis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • abdominal pain vomiting and acute pancreatitis present: 1, 2
    • abdominal pain vomiting and admission intubation: 1
    • abdominal pain vomiting and liver enzyme: 1, 2, 3, 4, 5, 6, 7
    • abdominal pain vomiting and logistic regression: 1, 2, 3, 4, 5, 6
    • abdominal pain vomiting nausea and acute pancreatitis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • abdominal pain vomiting nausea and acute pancreatitis present: 1, 2
    • abdominal pain vomiting nausea and admission intubation: 1
    • abdominal pain vomiting nausea and liver enzyme: 1, 2, 3
    • abdominal pain vomiting nausea and logistic regression: 1, 2, 3, 4
    • abdominal pain vomiting nausea include and acute pancreatitis: 1